Health
Moderna Covid-19 Vaccine Protects Against New Variants in Early Study
This article is for subscribers only.
Moderna Inc.’s updated Covid-19 shot provides some protection against two variants of the virus that are among those most widely circulating in the US, according to early results from a company study.
The vaccine significantly boosted levels of antibodies that target the EG.5 and FL.1.5.1 variants, Moderna said in a statement, citing unpublished clinical trial data. Those variants made up about 26% of Covid cases in the US earlier this month, according to estimates from the Centers for Disease Control and Prevention.